Back to search
FDAFDA · Food and drugs·Recall number F-0262-2025

DesBio lunaSOMM Natural Sleep Support Dietary Supplement capsules, 30 count in a Blue PET bottle with a White cap. Supplement facts declare Phosphatidylserine (from non-GMO sunflower lecithin powder) 40 mg. Distributed by Deseret Biologicals Inc 469 West Parkland Dr, Sandy, UT.

Published December 18, 2024 · Recall initiated: October 30, 2024

Summary

FDA records food Class II recall F-0262-2025, published December 18, 2024 and initiated October 30, 2024. Recalling firm: Deseret Biologicals Inc; Status: Terminated; Reported quantity: 2547 bottles; Lot: LOT 020323126 MFG 04/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product contains undeclared soy lecithin.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Deseret Biologicals Inc
Distributor
Distributed nationwide, one foreign distributor to Australia. No DOD distribution. No VA.
Lot
LOT 020323126 MFG 04/2023
Risk classification
Class II
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was DesBio lunaSOMM Natural Sleep Support Dietary Supplement capsules, 30 count in a Blue PET bottle with a White cap. Supplement facts declare Phosphatidylserine (from non-GMO sunflower lecithin powder) 40 mg. Distributed by Deseret Biologicals Inc 469 West Parkland Dr, Sandy, UT. recalled?

Yes. FDA published recall F-0262-2025 on December 18, 2024. Reported hazard: Product contains undeclared soy lecithin.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit